Skip to main content
Log in

Neurochemichal aspects of the pharmacological effect of 2,3,4-trimethoxy-N’-(8-methyl-8-azabicyclo[3.2.1.] octan-3-ylidene) benzohydrazide hydrochloride (LK-933)

  • Experimental Articles
  • Published:
Neurochemical Journal Aims and scope Submit manuscript

Abstract

The objective of this study was to investigate the effects of 2,3,4-trimethoxy-N'-(8-metyl-8-azabicyclo[3.2.1.] octan-3-ylidene) benzohydrazide hydrochloride (LK-933), a compound of the tropane group with anxiolytic and antimigraine activity, on the levels of monoamines and their metabolites in different brain structures of outbred mice using HPLC–ED. Administration of LK-933 caused an increase in the composite characteristics that describe the rate of dopamine transformation into its metabolites dioxyphenylacetic acid and homovanillic acid in the frontal cortex by 114 and 181%, respectively. The levels of homovanillic acid in the same structure increased by 49%. These data implicate the dopaminergic pathway in the mechanism of LK-933 action.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kent, J., Mathew, S., and Gorman, J., Biol. Psychiat., 2002, vol. 52, pp. 1008–1030.

    Article  CAS  PubMed  Google Scholar 

  2. Hoyer, D. and Martin, G., Neuropharmacol., 1997, vol. 36, pp. 419–428.

    Article  CAS  Google Scholar 

  3. Clenet, F., Hascoet, M., Fillion, G., Galons, H., and Bourin, M., Behav. Brain Res., 2005, vol. 158, pp. 339–348.

    Article  CAS  PubMed  Google Scholar 

  4. Graeff, F.G., Netto, C.F., and Zangrossi, H., Jr., Neurosci. Behav. Rev., 1998, vol. 23, no. 2, pp. 237–246.

    Article  CAS  Google Scholar 

  5. Seredenin, S.B., and Voronin, M.V., Eksp. Klin. Farmakol., 2009, vol. 72, no. 1, pp. 3–10.

    CAS  Google Scholar 

  6. Becker, W.J., Headache, 2015, vol. 55, no. 6, pp. 778–93.

    Article  PubMed  Google Scholar 

  7. Sokolov, A.Yu., Lyubashina, O.A., and Panteleev, S.S., Neurochem. J., 2011, vol. 28, no. 2, pp. 104–112.

    Google Scholar 

  8. Mehrotra, S., Gupta, S., and Chan, K.Y., Naunyn-Schmiedebergs Arch. Pharmacol., 2008, vol. 378, no. 4, pp. 371–394.

    Article  CAS  PubMed  Google Scholar 

  9. Mirzoyan, R.S., Seredenin, S.B., Gan’shina, T.S., Kostochka, L.M., Romanycheva, N.A., and Rusakov, D.Yu., Eksp. Klin. Farmakol., 1998, vol. 61, no. 2, pp. 28–31.

    CAS  Google Scholar 

  10. Kozhechkin, S.N., Kostochka, L.M., Bezhanyan, S.G., Mirzoyan, R.S., and Seredenin, S.B., Eksp. Klin. Farmakol., 2005, vol. 68, no. 4, pp. 3–6.

    CAS  PubMed  Google Scholar 

  11. Bernstein, J., and Lott, W.A., US Patent 2838914, 1957.

    Google Scholar 

  12. Kostochka, L.M., Gan’shina, T.S., Naplekova, P.L., Narkevich, V.B., Voronina, T.A., Kudrin, V.S., Mirzoyan R.S., Kurdyumov, I.N., Gudasheva T.A., Zherdev, V.P., and Pyatin B.M., RF Patent application no. 2016133999, 2016.

    Google Scholar 

  13. Raevskii, K.S., Narkevich, V.B., and Klodt, P.M., Eksp. Klin. Farmakol., 2011, vol. 12, pp. 3–7.

    Google Scholar 

  14. De Deurwaerdere, P., Navailles, S., Berg, K.A, Clarke, W.P., and Spampinato, U., J. Neurosci., 2004, vol. 24, pp. 3235–3241.

    Article  PubMed  Google Scholar 

  15. Raevskii, K.S., Narkevich, V.B., Klodt, P.M., and Kudrin, V.S., Byull. Eksp. Biol. Med., 2012, vol. 153, no. 5, pp. 644–648.

    Article  Google Scholar 

  16. Blackburn, T.P., Suzuki, K., and Ashby, C.R., Jr., Synapse, 2006, vol. 59, pp. 502–512.

    Article  CAS  PubMed  Google Scholar 

  17. Duxon, M.S., Kennett, G.A., Lightowler, S., Blackburn, T.P., and Fone, K.C., Neuropharmacol., 1997, vol. 36, pp. 601–608.

    Article  CAS  Google Scholar 

  18. Nutt, D.J., CNS Spectr., 2005, vol. 10, pp. 49–56.

    Article  PubMed  Google Scholar 

  19. Kennett, G.A, Wood, M.D., Glen, A., Grewal, S., Forbes, I., Gadre, A., and Blackburn, T.P., Br. J. Pharmacol., 1994, vol. 111, pp. 797–802.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Jenck, F., Bos, M., Wichmann, J., Stadler, H., Martin, J.R., and Moreau, J.L., Exper. Opin. Investig. Drugs, 1998, vol. 7, no. 10, pp. 1587–1599.

    Article  CAS  Google Scholar 

  21. Pancoesi, A., Cefalalgia, 1997, vol. 17, pp. 3–14.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. L. Naplekova.

Additional information

Original Russian Text © P.L. Naplekova, V.B. Narkevich, V.S. Kudrin, L.M. Kostochka, T.A. Voronina, 2017, published in Neirokhimiya, 2017, Vol. 34, No. 3, pp. 242–246.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Naplekova, P.L., Narkevich, V.B., Kudrin, V.S. et al. Neurochemichal aspects of the pharmacological effect of 2,3,4-trimethoxy-N’-(8-methyl-8-azabicyclo[3.2.1.] octan-3-ylidene) benzohydrazide hydrochloride (LK-933). Neurochem. J. 11, 242–245 (2017). https://doi.org/10.1134/S181971241702009X

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S181971241702009X

Keywords

Navigation